Please do not leave this page until complete. This can take a few moments.
Massachusetts-based multistate cannabis operator Curaleaf announced it is closing operations in three states, making it the second marijuana company with a large Connecticut presence to indicate it's facing major financial headwinds.
Curaleaf said late Thursday said it is closing a majority of its operations in California, Colorado and Oregon beginning this month. Further, the company will consolidate cultivation and processing operations in Massachusetts to the company’s facility in Webster, closing its Amesbury location.
Curaleaf CEO Matt Darin said the “states will represent opportunities in the future, but the current price compression caused by a lack of meaningful enforcement of the illicit market prevent us from generating an acceptable return on our investments.”
Curaleaf didn’t mention Connecticut operations in its announcement. The company is currently one of the state’s four active growers for medical and recreational marijuana and also operates medical dispensaries in Hartford, Milford and Groton. The company is hoping to convert it’s Hartford dispensary to hybrid operations, but has previously indicated plans to move that store to Manchester.
It also announced Friday morning that it has received approval from the Connecticut Department of Consumer Protection to open a recreational cannabis dispensary in Stamford, its first in the state.
Curleaf said the the Stamford store at 814 East Main St. will open Jan. 28, at 10 a.m.
As part of the nationwide closures, Curaleaf said it reduced its payroll by 10%. In total, the cost savings will help the company realize $60 million in “gross run-rate expense savings” this year, Curaleaf said.
With the closure of cultivation and production facilities in California, Colorado and Oregon, Curaleaf said it will shift focus to its core “revenue-driving markets.” The company had already begun cost-cutting measures in the three states in 2022. Curaleaf said the three markets contributed less than $50 million in revenue for the company in 2022.
Curaleaf said it expects free cash flow to exceed $125 million in 2023 following the closures.
Earlier this month, Greenrose Holding Co., a multistate cannabis operator based in New York that owns Connecticut cultivation facility Theraplant, announced it was marketing itself for a potential sale as a result of financial challenges it faces.
The Hartford Business Journal 2025 Charity Event Guide is the annual resource publication highlighting the top charity events in 2025.
Learn moreHartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
SubscribeDelivering vital marketplace content and context to senior decision-makers throughout Connecticut ...
All Year Long!
The Hartford Business Journal 2025 Charity Event Guide is the annual resource publication highlighting the top charity events in 2025.
Hartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
Delivering vital marketplace content and context to senior decision-makers throughout Connecticut ...
All Year Long!
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments